Georgetown Lombardi Comprehensive Cancer Center
Add to Favorites Newsroom RSS Share
Washington, DC USA

Our News on Newswise

Use of Electrical Brain Stimulation to Foster Creativity Has Sweeping Implications

In an article published in Creativity Research Journal, Georgetown researchers address neuro-ethical concerns associated with the increasing use of transcranial electrical stimulation (tES).
18-Sep-2018 12:00 PM EDT Add to Favorites

Georgetown Breast Cancer Advocates Make Their Case in Cancer Research Journal

Georgetown Breast Cancer Advocates (GBCA), a volunteer group of survivors and other advocates who support and promote cancer research at Georgetown University, have published an article that underscores ways in which both the scientific and advocacy...
15-Aug-2018 6:00 AM EDT Add to Favorites

Large Collection of Brain Cancer Data Now Easily, Freely Accessible to Global Researchers

A valuable cache of brain cancer biomedical data, one of only two such large collections in the country, has been made freely available worldwide by researchers at Georgetown Lombardi Comprehensive Cancer Center.
10-Aug-2018 6:00 AM EDT Add to Favorites

Georgetown University Medical Center Selected as Lewy Body Dementia Research Center of Excellence

The Lewy Body Dementia Association has designated Georgetown University Medical Center as a “Research Center of Excellence.”
4-Apr-2018 7:05 AM EDT Add to Favorites

Georgetown Among First Universities to Collaborate with the Coalition for Epidemic Preparedness Innovations U.S.

Georgetown University and CEPI U.S. – the Coalition for Epidemic Preparedness Innovations U.S. – today announce a new agreement to explore joint cooperative academic and research initiatives.
21-Mar-2018 9:05 AM EDT Add to Favorites

Family History Increases Breast Cancer Risk Even in Older Women: Weighing Screening Options

Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in aging women — those ages 65 and older, according to research published in JAMA Internal Medicine. The findings could impact...
8-Feb-2018 12:45 PM EST Add to Favorites

New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer

Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney...
8-Feb-2018 7:05 AM EST Add to Favorites

Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab

Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
26-Jan-2018 11:05 AM EST Add to Favorites


see all news

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.

Contacts

Karen Teber
Sr. Director, Strategic Communications

Katharine Zambon
Director of Communications

Twitter

Chat now!